OBJECTIVE: To investigate the incidence and severity of pituitary insufficiency after aneurysmal subarachnoid haemorrhage. METHODS: Pituitary function was tested in a series of patients more than 12 months but less than 60 months after aneurysmal subarachnoid haemorrhage using a combined TRH-LHRH-arginine test and the insulin tolerance test, to elucidate possible deficits in the gonadotrophic, somatotrophic, thyreotrophic, and corticotrophic hormonal axes. RESULTS: Of 21 patients screened, nine (43%) showed deficiencies of at least one pituitary hormone axis. Four patients had corticotrophin deficiency, one had partial growth hormone deficiency, two had severe growth hormone deficiency, and two had severe growth hormone deficiency plus corticotrophin deficiency. CONCLUSIONS: Persistent pituitary dysfunction may be more common after aneurysmal subarachnoid haemorrhage than has so far been recognised and warrants further investigation, given the possibility that some health and neurobehavioural problems in these patients could result from hormone deficiency.
OBJECTIVE: To investigate the incidence and severity of pituitary insufficiency after aneurysmal subarachnoid haemorrhage. METHODS: Pituitary function was tested in a series of patients more than 12 months but less than 60 months after aneurysmal subarachnoid haemorrhage using a combined TRH-LHRH-arginine test and the insulin tolerance test, to elucidate possible deficits in the gonadotrophic, somatotrophic, thyreotrophic, and corticotrophic hormonal axes. RESULTS: Of 21 patients screened, nine (43%) showed deficiencies of at least one pituitary hormone axis. Four patients had corticotrophin deficiency, one had partial growth hormone deficiency, two had severe growth hormone deficiency, and two had severe growth hormone deficiency plus corticotrophin deficiency. CONCLUSIONS: Persistent pituitary dysfunction may be more common after aneurysmal subarachnoid haemorrhage than has so far been recognised and warrants further investigation, given the possibility that some health and neurobehavioural problems in these patients could result from hormone deficiency.
Authors: G Parenti; P C Cecchi; B Ragghianti; A Schwarz; F Ammannati; P Mennonna; A Di Rita; P Gallina; N Di Lorenzo; P Innocenti; G Forti; A Peri Journal: J Endocrinol Invest Date: 2010-08-31 Impact factor: 4.256
Authors: L Khajeh; K Blijdorp; M H Heijenbrok-Kal; E M Sneekes; H J G van den Berg-Emons; A J van der Lely; D W J Dippel; S J C M M Neggers; G M Ribbers; F van Kooten Journal: J Neurol Neurosurg Psychiatry Date: 2014-11-06 Impact factor: 10.154
Authors: Stepani Bendel; Timo Koivisto; Esko Ruokonen; Jaakko Rinne; Jarkko Romppanen; Ilkka Vauhkonen; Vesa Kiviniemi; Ari Uusaro Journal: Crit Care Date: 2008-10-13 Impact factor: 9.097